Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability.
about
P1343
Epigenetic determinants of metastasisExposure to the widely used herbicide atrazine results in deregulation of global tissue-specific RNA transcription in the third generation and is associated with a global decrease of histone trimethylation in miceHarnessing protein kinase A activation to induce mesenchymal-epithelial programs to eliminate chemoresistant, tumor-initiating breast cancer cellsThe Natural cAMP Elevating Compound Forskolin in Cancer Therapy: Is It Time?Metabolic reprogramming and epithelial-to-mesenchymal transition in cancer.Functional and Structural Mimicry of Cellular Protein Kinase A Anchoring Proteins by a Viral OncoproteinActivation of PTHrP-cAMP-CREB1 signaling following p53 loss is essential for osteosarcoma initiation and maintenance.RB1 deficiency in triple-negative breast cancer induces mitochondrial protein translation.Beta-catenin participates in dialysate-induced peritoneal fibrosis via enhanced peritoneal cell epithelial-to-mesenchymal transition.Erythrocytes retain hypoxic adenosine response for faster acclimatization upon re-ascentDub3 inhibition suppresses breast cancer invasion and metastasis by promoting Snail1 degradation.SIRT6 Suppresses Cancer Stem-like Capacity in Tumors with PI3K Activation Independently of Its Deacetylase Activity.Triple negative breast cancer development can be selectively suppressed by sustaining an elevated level of cellular cyclic AMP through simultaneously blocking its efflux and decomposition.Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells.Dual Src Kinase/Pretubulin Inhibitor KX-01, Sensitizes ERα-negative Breast Cancers to Tamoxifen through ERα Reexpression.Functional characterization of AMP-activated protein kinase signaling in tumorigenesis.Collective migration and cell jamming in asthma, cancer and development.Targeting the Epithelial-to-Mesenchymal Transition: The Case for Differentiation-Based Therapy.The Cellular Origin and Evolution of Breast Cancer.EMT, CSCs, and drug resistance: the mechanistic link and clinical implications.The EMT spectrum and therapeutic opportunities.Epigenetics and Cancer Stem Cells: Unleashing, Hijacking, and Restricting Cellular Plasticity.Breast cancer stem cells as last soldiers eluding therapeutic burn: A hard nut to crack.Cellular responses to human cytomegalovirus infection: Induction of a mesenchymal-to-epithelial transition (MET) phenotype.Breast Carcinoma: From Initial Tumor Cell Detachment to Settlement at Secondary Sites.Depletion of mitochondrial reactive oxygen species downregulates epithelial-to-mesenchymal transition in cervical cancer cells.RGS19 upregulates Nm23-H1/2 metastasis suppressors by transcriptional activation via the cAMP/PKA/CREB pathwayThe Epithelial-to-Mesenchymal Transition in Breast Cancer: Focus on Basal-Like Carcinomas.Plant homeodomain finger protein 2 as a novel IKAROS target in acute lymphoblastic leukemia.Klf4 reduces stemness phenotype, triggers mesenchymal-epithelial transition (MET)-like molecular changes, and prevents tumor progression in nasopharygeal carcinoma.Expression of an active Gαs mutant in skeletal stem cells is sufficient and necessary for fibrous dysplasia initiation and maintenance.SUV420H2 is an epigenetic regulator of epithelial/mesenchymal states in pancreatic cancer.Down-regulating Myoferlin inhibits the vasculogenic mimicry of melanoma via decreasing MMP-2 and inducing mesenchymal-to-epithelial transition.Placenta-specific protein 1 promotes cell proliferation and invasion in non-small cell lung cancer.PDE5 inhibition eliminates cancer stem cells via induction of PKA signaling.New Advances and Challenges of Targeting Cancer Stem Cells.Histone Variant MacroH2A1 Plays an Isoform-Specific Role in Suppressing Epithelial-Mesenchymal Transition.Activated CD8+ T cell extracellular vesicles prevent tumour progression by targeting of lesional mesenchymal cells.The A2B Adenosine Receptor Modulates the Epithelial- Mesenchymal Transition through the Balance of cAMP/PKA and MAPK/ERK Pathway Activation in Human Epithelial Lung Cells.The epithelial-to-mesenchymal transition activator ZEB1 initiates a prometastatic competing endogenous RNA network.
P2860
Q28079377-F6E98327-C218-4F0D-A2B5-2EC79D410B87Q28314339-DF7567F0-D188-4625-941B-7D6190D385D8Q33865464-640C1A5C-4809-4C83-A02A-75216D8D8ABCQ34542598-B61441DF-7DF5-450F-AE96-0CBBB49DA101Q34555855-090717F1-3630-436C-B520-32705C5CE20DQ36006291-85CCC600-2FD7-41BD-AF1B-541C0DE4B3D4Q36862527-1FF6FC49-429D-4E6E-A867-066C49B8A15BQ37395680-CD895280-1B77-4D3D-A0F1-1D42109A9A03Q37625607-F2C11AEB-3F8A-45BF-8E86-C50A6A85D07DQ37642443-35E3FE21-BD36-4047-8009-9B5F631B2CA2Q37651974-BA33C5D7-885F-43A7-9279-3A9202BEA989Q37670666-B62A5B81-6187-49DA-BE70-CE905ED40F38Q37699405-34C32888-6B19-456D-B523-267958F3629EQ37730158-6E1114E5-1ABD-478C-B513-B9EFFC00CB90Q38656581-CAB0D4AA-834E-4F32-94DF-7CA6799E9379Q38807302-62942108-4551-420A-92C1-F7DB84581C56Q38934429-5F7B90FF-8C51-477C-A495-5AE3DA184BA3Q39069234-502053E7-A226-4E89-9CEC-A2413931FB60Q39071403-4E7D5BE5-6663-4EC1-8837-5B566A04AF19Q39233875-EE1CA473-6D60-473F-BA3C-B91C88EA0DD5Q39329818-25ED05BF-8275-4B19-9975-1ADE27989A1EQ39441283-CFFFEF15-5F37-46B6-9AEB-58373CC4BBDFQ39443694-D4EFC4E8-4159-4C69-BF89-6F1958C783A2Q40056844-C3CCBC01-00EF-4D95-87C3-184DDFDF3756Q41141633-DC16638A-8E24-4A7A-A738-4668A8474189Q41963397-F54B6594-B8A9-4EE6-9DFC-089CF40CD7E6Q42378395-5F1A66AA-9562-4F2F-8787-E1B5BC696DE1Q42516196-E3950637-AE84-4470-8B8D-D11B4EA0A7E7Q45970621-940A6AB8-E5D2-4BED-BB16-A1C8249A44ADQ47139880-9D8EE2B7-DCF1-45AD-AD11-C37885EA4284Q47250948-91C08990-AA95-4274-93E5-ADF3906F7313Q47327498-14BA1843-51F9-438A-88BC-B4C234A179E4Q47374773-67DBD0DE-C1C8-4287-A453-F98AFEACEEC7Q47401259-59DA8643-E520-4897-A035-1CE301392CBCQ48507592-E64D53FE-5BDD-494B-B6FF-1369C40E39FDQ48588244-5D64EF93-D2E2-4521-AC37-B05846B1AF1DQ49218448-4F3966E6-A48D-4270-BD2E-7B58542AA1F9Q49246137-BB5ADBB9-224E-44B2-BDF1-7D95B5B8F30EQ50041957-66D87A96-42DF-434E-8736-47D7756831C4Q50087312-AF6E5729-3B66-460D-8B42-4D5ED29F9547
P2860
Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability.
description
2016 nî lūn-bûn
@nan
2016 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մարտին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Activation of PKA leads to mes ...... s of tumor-initiating ability.
@ast
Activation of PKA leads to mes ...... s of tumor-initiating ability.
@en
Activation of PKA leads to mes ...... s of tumor-initiating ability.
@nl
type
label
Activation of PKA leads to mes ...... s of tumor-initiating ability.
@ast
Activation of PKA leads to mes ...... s of tumor-initiating ability.
@en
Activation of PKA leads to mes ...... s of tumor-initiating ability.
@nl
prefLabel
Activation of PKA leads to mes ...... s of tumor-initiating ability.
@ast
Activation of PKA leads to mes ...... s of tumor-initiating ability.
@en
Activation of PKA leads to mes ...... s of tumor-initiating ability.
@nl
P2093
P2860
P50
P356
P1433
P1476
Activation of PKA leads to mes ...... s of tumor-initiating ability.
@en
P2093
Christina Zill
Jordan A Krall
Katharina Isabelle Kober
Prathapan Thiru
P2860
P304
P356
10.1126/SCIENCE.AAD3680
P407
P4510
P577
2016-03-01T00:00:00Z